Bivalent COVID-19 boosters offer stronger protection for seniors, Australian study reveals

Study compares the effectiveness of bivalent and monovalent booster vaccines against COVID-19 mortality in individuals aged 65 and older. It finds that bivalent boosters show higher vaccine effectiveness against COVID-19 mortality, particularly for the Omicron variant, compared to monovalent vaccines.

Biotech FogPharma raises $145 million in anticipation of more clinical trials, pharma partnerships

Oncology startup FogPharma just closed a $145 million Series E round, the company confirmed, reaching a late stage of financing that few other biotechs have

March 1, 2024

Opinion | Healthcare’s Post-Traumatic Growth

Mary Meyer MD, MPH, is an emergency physician with The Permanente Medical Group. She also holds a Master of Public Health and certificates in Global

September 25, 2024

Pharmalittle: We’re reading about a Merck drug-label controversy, Astellas pulling an application, and more

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so familiar routine of deadlines,

October 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.